Company profile
AVENUE THERAPEUTICS, INC. CIK 1644963
Ticker
ATXI (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Bay Harbor Islands, FL 33154
Fiscal year end
2025 (FY)
Key Financials
Revenue
$1.40M
Net income
-$2.91M
Total assets
$2.93M
Total liabilities
$1.10M
Stockholders' equity
$1.83M
Cash & equivalents
$2.86M
Operating income
-$3.08M
Operating cash flow
-$1.83M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-219.6%
Net margin
-207.2%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
37.5%
Equity / assets
62.5%
CapEx / revenue
—
Operating cash flow / net income
0.63×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$1.40M
-$2.91M
$2.93M
$1.10M
$1.83M
2024
$0
-$11.65M
$2.67M
$816.0K
$2.80M
2023
—
-$10.38M
$1.85M
$1.20M
$1.58M
2022
—
-$3.55M
$6.85M
$3.58M
$3.91M
2021
—
-$3.73M
$3.96M
$509.0K
$3.45M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-07
Financials filed via
Form 10-K
filed 2026-03-30
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Bay Harbor Islands, FL 33154
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:26 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.